RTW Venture Fund Limited Net Asset Value(s) (1607G)

TIDMRTW

RNS Number : 1607G

RTW Venture Fund Limited

14 November 2022

LEI: 549300Q7EXQQH6KF7Z84

14 November 2022

RTW Venture Fund Limited

Net Asset Value

RTW Venture Fund Limited (the "Company") announces that the unaudited net asset value attributable to the ordinary shares of the Company at the close of business on 31 October 2022 (the "NAV") was US$307 million, or US$1.45 per ordinary share, an increase of 0.6% from the previous month.

As at 31 October 2022, 26.9% of the total NAV was invested in privately-held core portfolio companies and 40.8% of the total NAV was invested in public core portfolio companies, most of which were initiated as private investments. 28.9% was invested in other liquid public positions (which mirror holdings in RTW Investments, LP private funds) in lieu of holding cash for future core investments.

For Further Information:

 
 RTW Investments, LP                         +44 (0) 77 1741 7711 
 Woody Stileman, Managing Director 
 
 Buchanan                                    +44 (0)20 7466 5107 
 Charles Ryland 
 Henry Wilson 
 George Beale 
 
 J.P. Morgan Cazenove                        +44 (0)20 7742 4000 
 William Simmonds 
 Jérémie Birnbaum 
 James Bouverat (Sales) 
 
 BofA Securities                             +44 (0) 20 7628 1000 
 Edward Peel 
 Kieran Millar 
 
 Elysium Fund Management Limited             +44 (0) 14 8181 0100 
 Joanna Duquemin Nicolle, Chief Executive 
  Officer 
 Sadie Morrison, Managing Director 
 
 Morgan Stanley Fund Services USA 
  LLC                                        +1 (914) 225 8885

Note :

 
    1.   The NAV is determined by the Company's investment manager, 
          RTW Investments, LP, in accordance with the Company's 
          accounting policies. Investments by the Company in privately-held 
          companies ("Private Portfolio Companies") have been valued 
          at fair market value, taking into account the valuation 
          prepared by Alvarez & Marsal Valuation Services LLC and 
          the nature, facts and circumstances of the Private Portfolio 
          Companies. Investments by the Company in companies listed 
          on a public stock exchange (the "Public Portfolio Companies") 
          have each been valued by reference to their market capitalisation 
          as at close of business on 31 October 2022. The Company 
          applies a valuation discount to its investments in Public 
          Portfolio Companies that are subject to post-IPO lock-up 
          provisions.

About RTW Venture Fund Limited:

RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the RTW website at www.rtwfunds.com for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVGPGAAGUPPGUG

(END) Dow Jones Newswires

November 14, 2022 02:00 ET (07:00 GMT)

Rtw Biotech Opportunities (LSE:RTW)
過去株価チャート
から 3 2024 まで 4 2024